Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHCGet Free Report) have been assigned a consensus rating of “Moderate Buy” from the nine ratings firms that are currently covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $87.56.

ACHC has been the topic of several research analyst reports. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 target price on the stock in a research report on Thursday, April 25th. TheStreet raised shares of Acadia Healthcare from a “c” rating to a “b-” rating in a research report on Monday, March 4th. Royal Bank of Canada reissued an “outperform” rating and issued a $94.00 target price on shares of Acadia Healthcare in a research report on Wednesday. StockNews.com cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Tuesday. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating and set a $90.00 price target on shares of Acadia Healthcare in a research report on Tuesday, March 5th.

Get Our Latest Stock Report on ACHC

Acadia Healthcare Stock Performance

Shares of NASDAQ ACHC opened at $66.27 on Thursday. The company has a 50-day simple moving average of $72.83 and a 200-day simple moving average of $76.98. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.27 and a quick ratio of 1.27. Acadia Healthcare has a 12 month low of $64.11 and a 12 month high of $87.77. The company has a market cap of $6.15 billion, a PE ratio of -473.32, a price-to-earnings-growth ratio of 1.99 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHCGet Free Report) last released its earnings results on Thursday, May 2nd. The company reported $0.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.80 by $0.04. Acadia Healthcare had a negative net margin of 0.38% and a positive return on equity of 11.49%. The business had revenue of $768.10 million for the quarter, compared to analysts’ expectations of $779.20 million. During the same period last year, the company earned $0.75 earnings per share. The company’s quarterly revenue was up 9.1% on a year-over-year basis. On average, equities analysts anticipate that Acadia Healthcare will post 3.53 earnings per share for the current year.

Insider Transactions at Acadia Healthcare

In other news, Director Wade D. Miquelon sold 2,203 shares of the business’s stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total transaction of $188,114.17. Following the transaction, the director now directly owns 46,074 shares of the company’s stock, valued at $3,934,258.86. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 2.00% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Headlands Technologies LLC bought a new stake in shares of Acadia Healthcare in the third quarter worth $25,000. GAMMA Investing LLC bought a new stake in shares of Acadia Healthcare in the fourth quarter worth $26,000. Mather Group LLC. bought a new stake in shares of Acadia Healthcare in the first quarter worth $48,000. Fifth Third Bancorp increased its stake in shares of Acadia Healthcare by 25.5% in the fourth quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock worth $52,000 after buying an additional 136 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale bought a new stake in shares of Acadia Healthcare in the third quarter worth $96,000.

About Acadia Healthcare

(Get Free Report

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Recommended Stories

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.